Saira Ramasastry is of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 40,485 shares of DAWN, which is worth approximately $517,803. The most recent transaction as insider was on Jun 21, 2024, when has been sold 10,000 shares (Common Stock) at a price of $13.19 per share, resulting in proceeds of $131,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.5K
0% 3M change
n/a 12M change
Total Value Held $517,803

Saira Ramasastry Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 21 2024
SELL
Open market or private sale
$131,900 $13.19 p/Share
10,000 Reduced 19.81%
40,485 Common Stock

Also insider at

SGMO
SANGAMO THERAPEUTICS, INC Healthcare
VIR
Vir Biotechnology, Inc. Healthcare
AKUS
Akouos, Inc. Healthcare
MIRM
Mirum Pharmaceuticals, Inc. Healthcare
SR

Saira Ramasastry

San Francisco, CA

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN